Journalist Georgina Kwarteng Launches Urgent Fundraiser to Cover Life-Saving Cancer Treatment

Georgina Afia Kwarteng, a 40-year-old Ghanaian journalist and public servant, is appealing to the public for financial support as she faces a critical battle against recurrent cancer. Having initially achieved remission following chemotherapy at Korle-Bu Teaching Hospital, Kwarteng's condition has relapsed, necessitating urgent and costly treatment abroad.

She has been diagnosed with Relapsed Nodular Sclerosing Hodgkin Lymphoma (Stage IIB), a malignancy affecting the lymphatic system. After completing six cycles of chemotherapy at Ghana's premier teaching hospital, doctors initially declared her cancer in remission. The devastating news of relapse has forced her medical team to explore more aggressive treatment options to save her life.

The Treatment Path Ahead

Kwarteng is currently undergoing salvage chemotherapy whilst preparing for an Autologous Stem Cell Transplant—a procedure in which her own bone marrow stem cells are harvested, treated, and reinfused to help her immune system fight the cancer more effectively. A specialist review by Dr. Ankit Jitani, a Consultant Hematologist and Bone Marrow Transplant Specialist based in India, has recommended this advanced treatment as her best chance for long-term recovery.

Beyond the transplant procedure itself, the financial burden extends to travel expenses, accommodation, and related medical costs. The total amount required stands at approximately US$25,000—a substantial sum for most Ghanaian families, particularly when facing medical emergencies.

Kwarteng has opened multiple channels for contributions: MTN Mobile Money (024 387 3627), a bank account at Consolidated Bank Ghana (Account: 0639346600001), and email contact at mamaauthentic21@gmail.com. Those unable to contribute financially have been encouraged to amplify her message by sharing her story across their networks.

Why It Matters for Ghana

Cancer remains a significant public health challenge across West Africa, and Ghana is no exception. The relapse of Kwarteng's condition underscores both the limitations of cancer care available locally and the financial vulnerabilities ordinary Ghanaians face when confronted with life-threatening illnesses requiring specialised international treatment.

Her case highlights a systemic issue: whilst Ghana's public healthcare institutions like Korle-Bu provide essential initial treatment, advanced procedures such as bone marrow transplants often remain inaccessible to the average citizen due to cost constraints and limited local infrastructure. This forces families to seek treatment abroad, multiplying expenses exponentially.

The appeal also reflects a cultural response deeply rooted in Ghanaian society—the mobilisation of community, religious organisations, and corporate entities to support individuals facing catastrophic health challenges. Such collective action, though essential for individual survival, also exposes gaps in comprehensive health insurance coverage and government support systems for cancer patients.

Kwarteng's public profile as a journalist and public servant has made her case more visible than countless others facing similar circumstances. Her willingness to share her medical journey openly may help raise awareness about both the prevalence of cancer recurrence and the financial realities patients encounter when pursuing life-saving treatment.